Search

Your search keyword '"Hartkopf AD"' showing total 13 results
Start Over Author "Hartkopf AD" Journal cancer research
13 results on '"Hartkopf AD"'

1. Abstract GS5-07: International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer: Results from the PADDY study

Author

Hartkopf, AD, primary, Brucker, SY, additional, Taran, F-A, additional, Harbeck, N, additional, von Au, A, additional, Naume, B, additional, Pierga, J-Y, additional, Hoffmann, O, additional, Beckmann, MW, additional, Rydén, L, additional, Fehm, T, additional, Aft, R, additional, Montserrat, S, additional, Walter, V, additional, Rack, B, additional, Schuetz, F, additional, Borgen, E, additional, Ta, M-H, additional, Bittner, A-K, additional, Fasching, P, additional, Fernö, M, additional, Krawczyk, N, additional, Weilbaecher, K, additional, Margelí, M, additional, Hahn, M, additional, Jueckstock, J, additional, Domschke, C, additional, Bidard, F-C, additional, Kasimir-Bauer, S, additional, Schoenfisch, B, additional, Kurt, AG, additional, Wallwiener, M, additional, Gebauer, G, additional, Wallwiener, D, additional, Janni, W, additional, and Pantel, K, additional

Published
2019
Full Text
View/download PDF

2. Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)

Author

Müller, V, primary, Huober, J, additional, Volz, B, additional, Overkamp, F, additional, Kolberg, H-C, additional, Hadji, P, additional, Haeberle, L, additional, Ettl, J, additional, Hartkopf, AD, additional, Lux, MP, additional, Lüftner, DI, additional, Wallwiener, M, additional, Taran, F-A, additional, Beckmann, MW, additional, Belleville, E, additional, Wimberger, P, additional, Hielscher, C, additional, Geberth, M, additional, Lermann, J, additional, Abenhardt, A, additional, Kurbacher, C, additional, Wuerstlein, R, additional, Thomssen, C, additional, Untch, M, additional, Janni, W, additional, Fehm, TN, additional, Brucker, SY, additional, Wallwiener, D, additional, Schneeweiss, A, additional, Fasching, PA, additional, and Tesch, H, additional

Published
2019
Full Text
View/download PDF

3. Abstract P6-17-37: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167)

Author

Lux, MP, primary, Hartkopf, AD, additional, Huober, J, additional, Volz, B, additional, Taran, F-A, additional, Overkamp, F, additional, Hadji, P, additional, Tesch, H, additional, Haeberle, L, additional, Ettl, J, additional, Lueftner, DI, additional, Wallwiener, M, additional, Müller, V, additional, Beckmann, MW, additional, Belleville, E, additional, Wimberger, P, additional, Hielscher, C, additional, Geberth, M, additional, Lermann, J, additional, Abenhardt, W, additional, Kurbacher, C, additional, Wuerstlein, R, additional, Thomssen, C, additional, Untch, M, additional, Fasching, PA, additional, Janni, W, additional, Fehm, TN, additional, Wallwiener, D, additional, Brucker, SY, additional, Schneeweiss, A, additional, and Kolberg, H-C, additional

Published
2019
Full Text
View/download PDF

4. Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Author

Wallwiener, M, primary, Nabieva, N, additional, Haeberle, L, additional, Taran, FA, additional, Hartkopf, AD, additional, Volz, B, additional, Overkamp, F, additional, Brandl, AL, additional, Kolberg, H-C, additional, Hadji, P, additional, Tesch, H, additional, Ettl, J, additional, Lux, MP, additional, Lueftner, D, additional, Belleville, E, additional, Fasching, PA, additional, Janni, W, additional, Beckmann, MW, additional, Wimberger, P, additional, Hielscher, C, additional, Fehm, T, additional, Brucker, SY, additional, Wallwiener, D, additional, Schneeweiss, A, additional, and Mueller, V, additional

Published
2018
Full Text
View/download PDF

5. Abstract P5-21-09: Overall survival of metastatic breast cancer patients – data from the PRAEGNANT breast cancer registry

Author

Taran, F-A, primary, Fasching, PA, additional, Volz, B, additional, Huober, J, additional, Overkamp, F, additional, Kolberg, HC, additional, Hadji, P, additional, Tesch, H, additional, Haeberle, L, additional, Ettl, J, additional, Lux, MP, additional, Hartkopf, AD, additional, Lueftner, D, additional, Wallwiener, M, additional, Müller, V, additional, Beckmann, MW, additional, Belleville, E, additional, Wimberger, P, additional, Hielscher, C, additional, Geberth, M, additional, Fersis, N, additional, Abenhardt, W, additional, Kurbacher, C, additional, Wuerstlein, R, additional, Thomssen, C, additional, Untch, M, additional, Janni, W, additional, Fehm, TN, additional, Wallwiener, D, additional, Brucker, SY, additional, and Schneeweiss, A, additional

Published
2018
Full Text
View/download PDF

7. Abstract P3-11-07: Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry

Author

Huober, J, primary, Fasching, PA, additional, Taran, F-A, additional, Volz, B, additional, Overkamp, F, additional, Kolberg, HC, additional, Hadji, P, additional, Tesch, H, additional, Haeberle, L, additional, Ettl, J, additional, Hartkopf, AD, additional, Lux, MP, additional, Lueftner, D, additional, Wallwiener, M, additional, Mueller, V, additional, Beckmann, MW, additional, Belleville, E, additional, Wimberger, P, additional, Hielscher, C, additional, Geberth, M, additional, Fersis, N, additional, Abenhardt, W, additional, Kurbacher, C, additional, Wuerstlein, R, additional, Thomssen, C, additional, Untch, M, additional, Janni, W, additional, Wallwiener, D, additional, Brucker, SY, additional, Schneeweiss, A, additional, and Fehm, TN, additional

Published
2018
Full Text
View/download PDF

8. Abstract P1-07-20: Developing prognostic indicators of poor outcomes in PRAEGNANT metastatic breast cancer cohort

Author

Szeto, C, primary, Benz, S, additional, Nguyen, A, additional, Rübner, M, additional, Wallwiener, D, additional, Tesch, H, additional, Hadji, P, additional, Fehm, TN, additional, Janni, W, additional, Overkamp, F, additional, Lueftner, D, additional, Lux, MP, additional, Wallwiener, M, additional, Beckmann, MW, additional, Huebner, H, additional, Ettl, J, additional, Hartkopf, AD, additional, Mueller, V, additional, Taran, FA, additional, Belleville, E, additional, Schneeweiss, A, additional, Soon-Shiong, P, additional, Rabizadeh, S, additional, and Fasching, PA, additional

Published
2018
Full Text
View/download PDF

9. Abstract P3-11-05: Reliability and acceptance of e-based survey instruments for measuring patient reported outcomes (PRO) in breast cancer patients: First results of the ePROCOM study

Author

Wallwiener, M, primary, Simoes, E, additional, Hartkopf, AD, additional, Taran, F-A, additional, Keilmann, L, additional, Sickenberger, N, additional, Stevanovic, S, additional, Belleville, E, additional, Ladra, C, additional, Schneeweiss, A, additional, Wallwiener, D, additional, Brucker, SY, additional, and Graf, J, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results